InsidersTradesSigma
Follow the Baijin Life Science Holdings Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on HK HK, under the supervision of HKEX. Operating in the Retail sector, Baijin Life Science Holdings Ltd. has recorded 9 reports. Market capitalisation: €484.8m. The latest transaction was filed on 29 April 2026 (Purchase). Among the most active insiders: CHENG Chi Kin. All data is free.
9
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
3Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,690 of 26,127 companies
25.0
score / 100
Value29
Quality21
FCF yld-3.1%
Earn yld-0.0%
EV/EBITDA·
ROE-25%
Gross mgn31%
Net mgn-0.2%
Debt/EBITDA16.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 April 2026
Declarations9 total
1,000,000 sharesShareXHKGHKEX:DA20260428E00528
Ideal exit: 19 Jan 2027 (T+270)
932,000 sharesShareXHKGHKEX:DA20260428E00519
Ideal exit: 19 Jan 2027 (T+270)
2,000,000 sharesShareXHKGHKEX:DA20260428E00340
Ideal exit: 19 Jan 2027 (T+270)
2,933,765 sharesShareXHKGHKEX:DA20260429E00164
Ideal exit: 19 Jan 2027 (T+270)
9,322,540 sharesShareXHKGHKEX:DA20260428E00086
Ideal exit: 19 Jan 2027 (T+270)
932,000 sharesShareXHKGHKEX:DA20260428E00295
Ideal exit: 19 Jan 2027 (T+270)
9 of 9 declarations